gene editing

The UK has approved Casgevy, a groundbreaking geneediting drug using CRISPR technology, for treating beta thalassaemia and sickle cell disease. This innovative treatment modifies the DNA of patients to effectively combat these genetic disorders. In other news, new legislation has been enacted in the UK to address the rights and duties of remote workers, the forestry department has held the electricity authority responsible for forest fires, and significant improvements have been made to the LarnacaNicosia highway to ease traffic congestion. Stay tuned to Cyprus Mail for more updates.